Effects of various vehicles and fatty acids on the skin permeation of lornoxicam

Journal of Pharmaceutical Investigation

Volumn 42, Issue 5, 2012, Pages 235-241

  Lee, Joo Hyun ^a   Chun, In Koo ^a  

^a Dongduk Women's University   (South Korea)

Author keywords

Fatty acids; Lornoxicam; Transdermal permeation; Triethanolamine; Vehicles

Indexed keywords

1 METHYL 2 PYRROLIDINONE; DECANOIC ACID; DIETHYLENE GLYCOL MONOETHYL ETHER; DIMETHYL SULFOXIDE; GLYCEROL OLEATE; LAURIC ACID; LINOLEIC ACID; LORNOXICAM; MEDIUM CHAIN TRIACYLGLYCEROL; MELOXICAM; OCTANOIC ACID; OLEIC ACID; OLEYL ALCOHOL; PROPANEDIOL DERIVATIVE; PROPYLENE GLYCOL; PROPYLENE GLYCOL DICAPRYLOCAPRATE; PROPYLENE GLYCOL MONOCAPRYLATE; PROPYLENE GLYCOL MONOLAURATE; TRIETHANOLAMINE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG PENETRATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION;

EID: 84876586377     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-012-0035-2     Document Type: Article

References (31)

1. Ammar HO, Ghorab M, Mahmoud AA, Makram TS, Noshi SH (2012) Topical liquid crystalline gel containing lornoxicam/cyclodextrin complex. J Incl Phenom Macrocycl Chem 73: 161-175.
2. Balfour JA, Fitton A, Barradell LB (1996) Lornoxicam: a review of its pharmacology and therapeutic potential in the management of painful and inflammatory conditions. Drugs 51: 639-657.
3. Barry BW (1983) Dermatological formulations. Marcel Dekker, New York, pp 49-94.
4. Bonnabry P, Leemann T, Dayer P (1996) Role of human liver microsomal CYP2C9 in the biotransformation of lornoxicam. Eur J Clin Pharmacol 9: 305-308.
5. Buritova J, Besson J-M (1998) Dose-related anti-inflammatory/analgesic effects of lornoxicam: a spinal c-Fos protein study in the rat. Inflamm Res 47: 18-25.
6. Cable CG (2003) Dimethyl sulfoxide. In: Rowe RC, Sheskey PJ, Weller PJ (eds) Handbook of pharmaceutical excipients, 4th edn. Pharmaceutical-American Pharmaceutical Association, London-Chicago, pp 219-221.
7. Fang L, Kobayashi Y, Numajiri S, Kobayashi D, Sugibayashi K, Morimoto Y (2002) The enhancing effect of a triethanolamine-ethanol-isopropyl myristate mixed system on the skin permeation of acidic drugs. Biol Pharm Bull 25: 1339-1344.
8. Fang L, Numajiri S, Kobayashi D, Morimoto Y (2003) The use of complexation with alkanolamines to facilitate skin permeation of mefenamic acid. Int J Pharm 262: 13-22.
9. Ganem-Quintanar A, Lafforgue C, Falson-Rieg F, Buri P (1997) Evaluation of the transepidermal permeation of diethylene glycol monoethyl ether and skin water loss. Int J Pharm 147: 165-172.
10. Golden GM, McKie JE, Potts RO (1987) Role of stratum corneum lipid fluidity in transdermal drug flux. J Pharm Sci 76: 25-28.
11. Gorukanti SR, Li L, Kim K (1999) Transdermal delivery of antiparkinsonian agent, benztropine. I. effect of vehicles on skin permeation. Int J Pharm 192: 159-172.
12. Gwak HS, Chun IK (2002) Effects of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin. Int J Pharm 236: 57-64.
13. Hitzenberger G, Welte SR, Takacs F, Rosenow D (1990) Pharmacokinetics of lornoxicam in man. Postgrad Med J 66: S22-S26.
14. Homdrum EM, Likar R, Nell G (2006) Xefo Rapid: a novel effective tool for pain treatment. Eur Surg 38: 342-352.
15. Kanikkannan N, Kandimalla K, Lamba SS, Singh M (2000) Structures activity relationship of chemical penetration enhancers in transdermal drug delivery. Curr Med Chem 7: 593-608.
16. Kligman AM (1965) Topical pharmacology and toxicology of dimethyl sulfoxide. J Am Med Assoc 193: 796-804.
17. Komata Y, Kaneko A, Fujie T (1992) In vitro percutaneous absorption of thiamine disulfide through rat skin from a mixture of propylene glycol and fatty acid or its analog. Chem Pharm Bull 40: 2173-2176.
18. Komata Y, Kaneko A, Fujie T (1994) Effect of fatty acid on the accumulation of thiamine disulfide in rat skin. Biol Pharm Bull 17: 705-708.
19. McCormack K (1999) The evolving NSAID: focus on lornoxicam. Pain Rev 6: 262-278.
20. Mura P, Faucci MT, Bramanti G, Corti P (2000) Evaluation of transcutol as a clonazepam transdermal permeation enhancer from hydrophilic gel formulations. Eur J Pharm Sci 9: 365-372.
21. Nanayakkara GR, Bartlett A, Forbes B, Marriott C, Whitfield PJ, Brown MB (2005) The effect of unsaturated fatty acids in benzyl alcohol on the percutaneous permeation of three model penetrants. Int J Pharm 301: 129-139.
22. Oertel RP (1977) Protein conformational changes induced in human stratum corneum by organic sulfoxides: an infrared spectroscopic investigation. Biopolymers 16: 2329-2345.
23. Pathan IB, Setty CM (2009) Chemical penetration enhancers for transdermal drug delivery system. Trop J Pharm Res 8: 173-179.
24. Pruss TP, Stroibnig H, Welte SR, Wendtlandt W, Mehdi N, Takacs F (1990) Overview of the pharmacological properties, pharmacokinetics and animal safety assessment of lornoxicam. Postgrad Med J 66(Suppl. 4): S18-S21.
25. Sahoo M, Syal P, Ingale S, Ingale K, Sindhe S, Sali M, Choudhari VP, Kuchekar BS (2011) Development and validation of a RP-HPLC-PDA method for simultaneous determination of lornoxicam and thiocolchicoside in pharmaceutical dosage form and its application for dissolution study. Int J Res Pharm Sci 2: 1-7.
26. Sato K, Sugibayashi K, Morimoto Y (1991) Species differences in percutaneous absorption of nicorandil. J Pharm Sci 80: 104-107.
27. Skjodt NM, Davies NM (1998) Clinical pharmacokinetics of lornoxicam. a short half-life oxicam. Clin Pharmacokinet 34: 421-428.
28. Tanojo H, Bouwstra JA, Junginger HE, Bodde HE (1997) In vitro human skin barrier modulation by fatty acids: skin permeation and thermal analysis studies. Pharm Res 14: 42-49.
29. Wang MY, Yang YY, Heng PWS (2004) Role of solvent in interactions between fatty acids based formulations and lipids in porcine stratum corneum. J Control Rel 94: 207-216.
30. Wester RC, Maibach HI (1989) In vivo methods for percutaneous absorption measurements. In: Brounaugh RL, Maibach HI (eds) Percutaneous Absorption: Mechanisms, Methodology, Drug Delivery, 2nd edn. Marcel Dekker, New York, pp 215-237.
31. Williams AC, Barry BW (2004) Penetration enhancers. Adv Drug Deliv Rev 56: 603-618.